CoChat

Inhibition of inducible nitric oxide synthase and cyclooxygenase‐2 in lipopolysaccharide‐stimulated RAW264.7 cells by carboxybutyrylated glucosamine takes place via down‐regulation of mitogen‐activated protein kinase‐mediated nuclear factor‐κB signaling

Open access
Rajapakse, Niranjan, Kim, Moon‐Moo, Mendis, Eresha, Kim, Se‐Kwon · 2008 · Immunology
Cited by 127

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Summary: Glucosamine (GlcN) has been reported to possess several biomedical properties, and currently a great deal of attention has been focused on improving the functional properties of GlcN for different applications. Therefore, this study was conducted to introduce a carboxybutyryl functional group to GlcN and to find out the inhibitory mechanism of a novel GlcN derivative, carboxybutyrylated GlcN (CGlcN), on the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase‐2 (COX‐2) in bacterial lipopolysaccharide (LPS)‐induced mouse macrophages (RAW264.7 cells). In the initial experiments, the production of NO and prostaglandin E 2 (PGE 2) was inhibited by CGlcN pretreatment and suggested the possibility of down‐regulating their respective genes, iNOS and COX‐2. Reverse transcription‐polymerase chain reaction and Western blot analysis revealed that CGlcN can affect both transcriptional and translational levels of iNOS and COX‐2 expression. The data from the nuclear factor‐κB (NF‐κB) promoter gene transfection experiment supported the idea that inhibition of iNOS and COX‐2 is caused by the down‐regulation of their transcription factor, NF‐κB. Following stimulation with LPS, p38 mitogen‐activated protein kinase (p38 MAPK) and c‐Jun N‐terminal kinase (JNK) present upstream of NF‐κB signaling were also inhibited by CGlcN treatment. However, the protein level of another MAPK, extracellular signal‐regulated kinase (ERK), remained unaffected. Moreover, following treatment with CGlcN, the protein expression of I‐κB kinase (IKK) clearly confirmed that its down‐regulation directly inhibited the degradation of IκB and release of NF‐κB. Therefore, it can be concluded that CGlcN is capable of inhibiting iNOS and COX‐2 expression in LPS‐induced RAW264.7 cells via attenuation of NF‐κB signaling by p38 MAPK and JNK, but not by ERK.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2567.2007.02683.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 127

Metadata

Authors
Rajapakse, N., Kim, M., Mendis, E., & Kim, S.
Venue
Immunology
Publisher
Wiley
Published
2008-01-18
Volume
123
Issue
3
Pages
348-357
ISSN
  • 0019-2805 (ISSN-L)
  • 1365-2567
OpenAlex
W2039375190
Cited by
127
References
2
FWCI
2.32
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inhibition of inducible nitric oxide synthase and cyclooxygenase‐2 in lipopolysaccharide‐stimulated RAW264.7 cells by carboxybutyrylated glucosamine takes place via down‐regulation of mitogen‐activated protein kinase‐mediated nuclear factor‐κB signaling. https://app.cochat.ai/papers/10.1111/j.1365-2567.2007.02683.x
The paper
Rajapakse, N., Kim, M., Mendis, E., & Kim, S. (2008). Inhibition of inducible nitric oxide synthase and cyclooxygenase‐2 in lipopolysaccharide‐stimulated RAW264.7 cells by carboxybutyrylated glucosamine takes place via down‐regulation of mitogen‐activated protein kinase‐mediated nuclear factor‐κB signaling. Immunology. https://doi.org/10.1111/j.1365-2567.2007.02683.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.